Neoplasia/BPH

	Uncovering the diagnostic potential of seminal fluid beyond fertility: cfDNA methylation analysis for the detection of clinically significant prostate cancer. PLoS One Geis J, Smith JF, Maddala T, Thoreson G, Michel K, Kaminetsky J, Belkoff L, Huang S, Griscom B, Hart JC, Bench S, Ardalani H, Rivas-Yepes L, Civello D, Clark-Langone KM. PMID: 42715227 [PubMed - indexed for MEDLINE]
	Immune-checkpoint inhibitor-induced bullous pemphigoid in patients with metastatic renal cell carcinoma: two case reports and systematic review of the literature. Acta Oncol Filis P, Lindskog M, Curman P, Kuzmina N, Krantz Å, Chatzidionysiou K, Costa Svedman F, Zerdes I. PMID: 42714143 [PubMed - indexed for MEDLINE]
	PD09-07 Durvalumab in Combination with Bacillus Calmette-GuÃ©rin for Bacillus Calmette-GuÃ©rin-NaÃ¯ve, High-Risk Non-Muscle-Invasive Bladder Cancer: Primary Results from a US-Based, Phase IIIB, Open-Label, Single-Arm, Multicenter Study (PATAPSCO): Erratum. J Urol Jayram G, Shore ND, Tyson M, Pieczonka C, Treasure P, Gadzinski A, Mazzarella B, Hodari M, Glover K, Hardikar S, Hahn NM. PMID: 42713894 [PubMed - in process]
	Holmium laser enucleation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. Cochrane Database Syst Rev Sathianathen N, Hwang EC, Brown SJ, Bakker C, Borofsky MS, Ergun O, Dahm P. PMID: 42713842 [PubMed - indexed for MEDLINE]
	Predicting postoperative acute kidney injury after colorectal cancer surgery: development and internal validation of a clinical prediction model using a nationwide cohort. BJS Open Skovsgaard M, Munch PV, Heide-Jørgensen U, Iversen LH, Christiansen CF. PMID: 42713840 [PubMed - indexed for MEDLINE]
	Resveratrol in benign prostatic hyperplasia: mechanistic insights and therapeutic perspectives. Front Immunol Jiang B, Zhang T, Yu M, You Y, Liu H, Li J, Zhang P. PMID: 42713291 [PubMed - indexed for MEDLINE]
	Comparison of Beiyi(Â®) and its reference product Enantone(Â®) as agonists of luteinizing hormone-releasing hormone against prostate cancer: a multicenter, randomized single-dose study. Front Pharmacol Yi Y, Shen P, Zheng T, Hou R, Fan L, Yu Y, Li J, Fang Y, Hao C, You P, Lu X, Lu X, Wei Q, Feng P. PMID: 42713047 [PubMed]
	Prognostic effect of the preoperative albumin-to-globulin ratio bladder cancer: a meta-analysis. Front Med (Lausanne) Huang F, Chen C, Mao Y, Lin T, Hu Q. PMID: 42712354 [PubMed]
	Metal artifact reduction for 3 T MRI-only prostate radiotherapy in patients with hip prostheses: impact on target definition, synthetic CT generation, dose calculation, and fiducial marker identification. Radiat Oncol Coskun M, Petersson JS, Wetterstedt SA, Brynolfsson P, Gustafsson CJ, Gunnlaugsson A, Olsson LE, Siversson C. PMID: 42711722 [PubMed - indexed for MEDLINE]
	Impact of Treatment Intensification with Abiraterone on Fracture-related Hospitalisation in Newly Diagnosed Prostate Cancer: A Secondary Analysis of Two Randomised Phase 3 Trials Within the STAMPEDE Trial Platform. Eur Urol Gray S, Dutey-Magni P, Jones C, Murphy LR, Murray ML, Brown JE, McCloskey E, Brown M, Amos CL, Gilbert DC, Jones RJ, Cross W, Matheson D, Millman R, STAMPEDE Collaborators, Parmar MKB, Sydes MR, Brown LC, Attard G, James ND, Clarke NW, Sachdeva A. PMID: 42711192 [PubMed - as supplied by publisher]
	Detected Huge Urinoma With 99mTc-PSMA Activity on Initial Prostate Cancer Staging. Clin Nucl Med Ahmadi M, Samadi MH, Saber Tanha A, Askari E, Aslzare M, Dabbagh Kakhki VR. PMID: 42710082 [PubMed - indexed for MEDLINE]
	Graph neural network-based risk stratification of prostate cancer using gene expression and SHAP interpretability. PLoS One Pirmoradi S, Vaghefi Moghaddam S, Ardalan M, Sharifi Bonab MM, Teshnehlab M, Zununi Vahed S. PMID: 42709904 [PubMed - indexed for MEDLINE]
	Deep learning for automatic detection of prostatectomy in CT images of prostate cancer patients. Phys Eng Sci Med Rainio O, Li A, Vehmanen A, Jaakkola MK, Kemppainen J, Klén R. PMID: 42709364 [PubMed - as supplied by publisher]
	Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck. Cancer Cytopathol Mercader C, Ingelmo-Torres M, Roldán FL, Figueras M, Villalba E, Galve P, Asiaín I, Costa M, Vilaseca A, Oriola J, Franco A, Alcaraz A, Mengual L. PMID: 42708821 [PubMed - indexed for MEDLINE]
	Research progress and clinical translation prospects of the urinary tract microbiome in prostate cancer. Front Immunol Li ZL, Qu RN, Liu SX, Wang W. PMID: 42707980 [PubMed - indexed for MEDLINE]
	Urinary Trace Element Concentrations in Congolese Patients With Prostate Cancer: A Case-Control Study. Prostate Cancer Mbey PM, Mukuku O, Saleh CU, Manika MM, Diangienda PDK, Moningo DM. PMID: 42707973 [PubMed]
	Frailty and [(177)Lu]Lu-PSMA-617 therapy: tools and strategies for older men with metastatic castration-resistant prostate cancer. Theranostics Bauckneht M, Borsellino N, Colloca GF, Fratino L, Santini D. PMID: 42707638 [PubMed - indexed for MEDLINE]
	Application of PathoChip to urine-derived nucleic acids for broad microbial profiling in men with suspected prostate cancer: setup of a methodological workflow and pilot feasibility study. J Liq Biopsy Mello-Grand M, Gregnanin I, Peraldo-Neia C, Ostano P, Guana F, Testino N, Malfitana V, Marchi G, Zaramella S, Robertson E, Chiorino G. PMID: 42707077 [PubMed]
	Lifestyle, anthropometric factors and clinically significant prostate cancer diagnosis in men with suspected prostate cancer. Scand J Urol Heiskanen E, Kalinen S, Chu RJ, Högerman M, Lamminen T, Taimen P, Jambor I, Aronen H, Merisaari H, Sainio T, Hakanen A, Ettala O, Laitinen K, Vasankari T, Kallonen T, Boström PJ, Promic study group. PMID: 42707024 [PubMed - indexed for MEDLINE]
	Artificial Intelligence in equivocal prostatic needle biopsies: benign mimics and cancer detection. Arch Ital Urol Androl Bawahab AA. PMID: 42707010 [PubMed - as supplied by publisher]

Articles 1 - 20 / 191123

Page 1 of 9557



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy